» Articles » PMID: 29334183

Engineering Polymersomes for Diagnostics and Therapy

Overview
Date 2018 Jan 16
PMID 29334183
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Engineered polymer vesicles, termed as polymersomes, confer a flexibility to control their structure, properties, and functionality. Self-assembly of amphiphilic copolymers leads to vesicles consisting of a hydrophobic bilayer membrane and hydrophilic core, each of which is loaded with a wide array of small and large molecules of interests. As such, polymersomes are increasingly being studied as carriers of imaging probes and therapeutic drugs. Effective delivery of polymersomes necessitates careful design of polymersomes. Therefore, this review article discusses the design strategies of polymersomes developed for enhanced transport and efficacy of imaging probes and therapeutic drugs. In particular, the article focuses on overviewing technologies to regulate the size, structure, shape, surface activity, and stimuli- responsiveness of polymersomes and discussing the extent to which these properties and structure of polymersomes influence the efficacy of cargo molecules. Taken together with future considerations, this article will serve to improve the controllability of polymersome functions and accelerate the use of polymersomes in biomedical applications.

Citing Articles

Advanced Nanomedicine Delivery Systems for Cardiovascular Diseases: Viral and Non-Viral Strategies in Targeted Therapy.

Chen Q, Yu T, Gong J, Shan H Molecules. 2025; 30(4).

PMID: 40005272 PMC: 11858567. DOI: 10.3390/molecules30040962.


Drug delivery for age-related bone diseases: From therapeutic targets to common and emerging therapeutic strategies.

Bi J, Zeng J, Liu X, Mo C, Yao M, Zhang J Saudi Pharm J. 2024; 32(12):102209.

PMID: 39697472 PMC: 11653637. DOI: 10.1016/j.jsps.2024.102209.


Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy.

Negut I, Bita B Pharmaceutics. 2024; 16(4).

PMID: 38675124 PMC: 11053450. DOI: 10.3390/pharmaceutics16040463.


Polymeric Nanoparticles for Drug Delivery.

Beach M, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y Chem Rev. 2024; 124(9):5505-5616.

PMID: 38626459 PMC: 11086401. DOI: 10.1021/acs.chemrev.3c00705.


USE OF ARTIFICIAL CELLS AS DRUG CARRIERS.

Diltemiz S, Tavafoghi PhD M, de Barros N, Kanada M, Heinamaki J, Contag C Mater Chem Front. 2024; 5(18):6672-6692.

PMID: 38344270 PMC: 10857888. DOI: 10.1039/d1qm00717c.


References
1.
Smith C, Shkumatov A, Withers S, Yang B, Glockner J, Misra S . A polymeric fastener can easily functionalize liposome surfaces with gadolinium for enhanced magnetic resonance imaging. ACS Nano. 2013; 7(11):9599-610. PMC: 3880799. DOI: 10.1021/nn4026228. View

2.
Hickey R, Koski J, Meng X, Riggleman R, Zhang P, Park S . Size-controlled self-assembly of superparamagnetic polymersomes. ACS Nano. 2013; 8(1):495-502. PMC: 5540317. DOI: 10.1021/nn405012h. View

3.
Gamcsik M, Kasibhatla M, Teeter S, Colvin O . Glutathione levels in human tumors. Biomarkers. 2012; 17(8):671-91. PMC: 3608468. DOI: 10.3109/1354750X.2012.715672. View

4.
Khawaja A, Cassidy D, Al Shakarchi J, McGrogan D, Inston N, Jones R . Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines. Insights Imaging. 2015; 6(5):553-8. PMC: 4569598. DOI: 10.1007/s13244-015-0420-2. View

5.
Franc B, Acton P, Mari C, Hasegawa B . Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J Nucl Med. 2008; 49(10):1651-63. DOI: 10.2967/jnumed.108.055442. View